Bruxism and temporomandibular disorders (TMD) are common problems with the
jaw and chewing muscles. These conditions have many causes, including overactive
jaw muscles, stress or other psychological factors, and changes in how pain is
processed. Standard treatments, like mouthguards, physiotherapy, and medicines,
often help only a little. Because of this, Botox (botulinum toxin, BTX) is being used
more to relax overactive muscles and reduce pain. This review aimed to look at the
current evidence on how well Botox works, how safe it is, and how useful it is for
treating bruxism and TMD. We searched PubMed for full-text articles in English
and Polish from the last ten years (January, 2015 – September, 2025). We included
systematic reviews, meta-analyses, and clinical trials that studied Botox for bruxism
and TMD. The evidence shows that Botox can reduce jaw muscle activity, muscle
soreness, and pain in people with bruxism, especially when standard treatments do
not work. Studies show that people feel less pain, sleep better, and can do daily
activities more easily. However, the results for TMD that involve the jaw joint are
mixed. Meta-analyses often do not show that Botox works much better than a
placebo for overall pain or jaw movement, although it can help with sore spots in
the muscles. Botox is generally safe, and most side effects are mild and go away on
their own. More high-quality studies are needed to understand the best uses of
Botox, how well it works long-term, and the best ways to give the treatment.
Keywords: Botulinum Toxin, Bruxism, Temporomandibular Disorders (TMD),
Masticatory Muscles
